Design of peptide oxytocin antagonists w
β
Maurice Manning; Ling Ling Cheng; Stoytcho Stoev; Nga Ching Wo; W. Y Chan; Hazel
π
Article
π
2005
π
John Wiley and Sons
π
English
β 219 KB
The peptide oxytocin (OT) antagonist atosiban, approved for tocolytic use in Europe (under the tradename Tractocile), represents an important new therapeutic advance for the treatment of premature labor. This paper presents some new peptide OT antagonists which offer promise as superior tocolytics.